New ‘Pay One, Stay Two’ parking deal to boost Waverley town centres

New ‘Pay One, Stay Two’ parking deal to boost Waverley town centres

2025-10-27 — Farnham Herald

New Parking Initiative to Boost Waverley Town Centres Waverley Borough Council is trialing a new parking scheme, "Pay One, Stay Two", to encourage longer visits and increased spending in l…


Trump rules out vice presidential run to stay in power after 2028 - Jamaica Observer

Trump rules out vice presidential run to stay in power after 2028 - Jamaica Observer

2025-10-27 — Jamaica Observer

Trump Rejects Vice Presidential Run Donald Trump has ruled out running for vice president in the 2028 American election. Aboard Air…

Vesper Solar 600 MW Texas project shows how an agrivoltaics mindset can unlock prime sites

Vesper Solar 600 MW Texas project shows how an agrivoltaics mindset can unlock prime sites

2025-10-27 — pv magazine USA

Vesper Solar 600 MW Texas Project The Vesper Solar 600 MW Texas project demonstrates how an agrivoltaics mindset can unlock prime sites fo…

South Africa: SAHPRA Approves Lenacapavir for HIV Prevention

South Africa: SAHPRA Approves Lenacapavir for HIV Prevention

2025-10-27 — AllAfrica

South Africa Approves Lenacapavir for HIV Prevention South Africa's Health Product Regulatory Authority (SAHPRA) has approved lenacapavir,…

This ‘minor’ bird flu strain has potential to spark human pandemic

This ‘minor’ bird flu strain has potential to spark human pandemic

2025-10-27 — Nature

Bird Flu Strain H9N2: A Potential Threat to Humans A team of scientists has raised concerns about the H9N2 bird flu virus, which has adapt…

Ericsson, Nokia combine on research for 6G video

Ericsson, Nokia combine on research for 6G video

2025-10-27 — Mobile World Live

Ericsson and Nokia Collaborate on 6G Video Research Nokia, Ericsson, and the Fraunhofer Heinrich Hertz Institute have presented a proof-of…

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis

2025-10-27 — FinanzNachrichten.de

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, a clinical-stage global biopharmaceutical company…

Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

2025-10-27 — FinanzNachrichten.de

Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announ…

Top 10 at 11: Healthcare and tech lead ASX lower as CSL and Wisetech bleed - Stockhead

Top 10 at 11: Healthcare and tech lead ASX lower as CSL and Wisetech bleed - Stockhead

2025-10-27 — Stockhead

ASX Market Update The Australian stock market is experiencing a decline, led by significant losses in the healthcare and tech sectors, des…

Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

2025-10-27 — FinanzNachrichten.de

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of N…

Do the Warriors have enough to maximize Stephen Curry’s remaining years?

Do the Warriors have enough to maximize Stephen Curry’s remaining years?

2025-10-27 — SB Nation

Can the Warriors Maximize Stephen Curry's Remaining Years? Stephen Curry remains an exceptional player, and his supporting cast has improv…

© 2025 cyceron.org News Aggregator
About Us · Privacy Policy · Terms of Service · DMCA Notice